Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group

医学 心脏病学 内科学 左束支阻滞 铅(地质) 心力衰竭 捆绑 地貌学 地质学 复合材料 材料科学
作者
Pugazhendhi Vijayaraman,Bengt Herweg,Atul Verma,Parikshit S. Sharma,Syeda Atiqa Batul,Shunmuga Sundaram Ponnusamy,Robert D. Schaller,Óscar Cano,Manuel Molina‐Lerma,Karol Čurila,Wim Huybrechts,David R. Wilson,Leonard M. Rademakers,Praveen Sreekumar,Gaurav A. Upadhyay,Kevin Vernooy,Faiz A. Subzposh,Weijian Huang,Marek Jastrzębski,Kenneth A. Ellenbogen
出处
期刊:Heart Rhythm [Elsevier BV]
卷期号:19 (8): 1272-1280 被引量:78
标识
DOI:10.1016/j.hrthm.2022.04.024
摘要

Background Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) is effective in patients with heart failure, left bundle branch block (LBBB), and reduced left ventricular function. Left bundle branch area pacing (LBBAP) has been reported as an alternative option for CRT. Objective The purpose of this study was to assess the feasibility and outcomes of LBBAP in patients who failed conventional BVP because of coronary venous (CV) lead complications or who were nonresponders to BVP. Methods At 16 international centers, LBBAP was attempted in patients with conventional CRT indication who failed BVP because of CV lead complications or lack of therapeutic response to BVP. Heart failure hospitalization (HFH) and death, echocardiographic outcomes, procedural data, pacing parameters, and lead complications including CV lead failure are reported. Results LBBAP was successfully performed in 200 patients (CV lead failures 156; nonresponders 44) (age 68 ± 11 years; female 35%; LBBB 55%; right ventricular pacing 23%; ischemic cardiomyopathy 28%; nonischemic cardiomyopathy 63%; left ventricular ejection fraction [LVEF] ≤35% in 80%). Procedural duration was 119.5 ± 59.6 minutes, and fluoroscopy duration was 25.7 ± 18.5 minutes. LBBAP threshold and R-wave amplitudes were 0.68 ± 0.35 V @ 0.45 ms and 10.4 ± 5 mV at implant, respectively, and remained stable during mean follow-up of 12 ± 10.1 months. LBBAP resulted in significant QRS narrowing from 170 ± 28 ms to 139 ± 25 ms (P <.001) with V6 R-wave peak times of 85 ± 17 ms. LVEF improved from 29% ± 10% at baseline to 40% ± 12% (P <.001) during follow-up. The risk of death or HFH was lower in those with CV lead failure than in nonresponders (hazard ratio 0.357; 95% confidence interval 0.168–0.756; P = .007) Conclusion LBBAP is a viable alternative to CRT in patients who failed conventional BVP due to CV lead failure or who were nonresponders. Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) is effective in patients with heart failure, left bundle branch block (LBBB), and reduced left ventricular function. Left bundle branch area pacing (LBBAP) has been reported as an alternative option for CRT. The purpose of this study was to assess the feasibility and outcomes of LBBAP in patients who failed conventional BVP because of coronary venous (CV) lead complications or who were nonresponders to BVP. At 16 international centers, LBBAP was attempted in patients with conventional CRT indication who failed BVP because of CV lead complications or lack of therapeutic response to BVP. Heart failure hospitalization (HFH) and death, echocardiographic outcomes, procedural data, pacing parameters, and lead complications including CV lead failure are reported. LBBAP was successfully performed in 200 patients (CV lead failures 156; nonresponders 44) (age 68 ± 11 years; female 35%; LBBB 55%; right ventricular pacing 23%; ischemic cardiomyopathy 28%; nonischemic cardiomyopathy 63%; left ventricular ejection fraction [LVEF] ≤35% in 80%). Procedural duration was 119.5 ± 59.6 minutes, and fluoroscopy duration was 25.7 ± 18.5 minutes. LBBAP threshold and R-wave amplitudes were 0.68 ± 0.35 V @ 0.45 ms and 10.4 ± 5 mV at implant, respectively, and remained stable during mean follow-up of 12 ± 10.1 months. LBBAP resulted in significant QRS narrowing from 170 ± 28 ms to 139 ± 25 ms (P <.001) with V6 R-wave peak times of 85 ± 17 ms. LVEF improved from 29% ± 10% at baseline to 40% ± 12% (P <.001) during follow-up. The risk of death or HFH was lower in those with CV lead failure than in nonresponders (hazard ratio 0.357; 95% confidence interval 0.168–0.756; P = .007) LBBAP is a viable alternative to CRT in patients who failed conventional BVP due to CV lead failure or who were nonresponders.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
郑成功完成签到,获得积分10
1秒前
1秒前
杰杰小杰发布了新的文献求助10
1秒前
wangyaofeng完成签到,获得积分10
1秒前
拿荷叶的火炬完成签到 ,获得积分10
1秒前
青木聪聪完成签到,获得积分10
2秒前
厄尔尼诺完成签到,获得积分10
2秒前
暴躁咩完成签到,获得积分10
2秒前
行悟完成签到 ,获得积分10
2秒前
文献狗完成签到,获得积分10
3秒前
kobee完成签到 ,获得积分10
3秒前
劳资懒得起网名完成签到,获得积分10
3秒前
火星上期待完成签到,获得积分20
3秒前
Akim的应助被于生有你采纳,获得10
3秒前
12完成签到 ,获得积分10
4秒前
李霞客完成签到,获得积分10
4秒前
知性的夏槐完成签到 ,获得积分10
4秒前
聚散流沙完成签到,获得积分10
5秒前
小马甲的应助被馨镜采纳,获得20
5秒前
senna发布了新的文献求助10
5秒前
碧蓝的灵安完成签到,获得积分10
5秒前
无私的犀牛完成签到,获得积分10
6秒前
waiho完成签到,获得积分10
6秒前
benmao_mogu完成签到,获得积分10
6秒前
情怀的应助被吴趣采纳,获得10
7秒前
高高的夕阳完成签到,获得积分10
7秒前
中级中级完成签到,获得积分10
8秒前
神勇的保温杯完成签到,获得积分10
8秒前
六个大洋完成签到 ,获得积分10
8秒前
ll发布了新的文献求助10
9秒前
MINI发布了新的文献求助20
9秒前
10秒前
愉快洋葱完成签到,获得积分10
10秒前
天天向上的应助被陈陈陈采纳,获得50
10秒前
yyx完成签到,获得积分10
10秒前
张醒醒完成签到,获得积分20
10秒前
zz完成签到,获得积分10
10秒前
Lenacici完成签到,获得积分10
11秒前
kks569完成签到,获得积分10
11秒前
神一样的鸟完成签到 ,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039